Berenberg Bank analyst Kerry Holford maintained a Hold rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK975.00. The company’s shares closed yesterday at ...

It also provides other contract manufacturing services. Novo Holdings, the investment firm that has a controlling interest in Novo Nordisk, signed a $16.5 billion deal to buy Catalent in February ...

However, other studies have reached the opposite conclusion. Novo Nordisk's crown jewel is safe for now, and continues to drive its financial results higher. However, various potential headwinds ...

NBC News' Meagan Fitzgerald sits down with Novo Nordisk CEO Lars Jorgenson in Denmark to discuss the high costs and limited supply of the company's popular weight loss drugs, Ozempic and Wegovy ...

The diabetes medicine Ozempic has been a veritable cash cow for Novo Nordisk (NYSE: NVO). The company's revenue, earnings, and stock price have been on a tear in recent years -- and no single drug ...

In an exclusive interview, NBC News’ Megan Fitzgerald sits down with Novo Nordisk CEO Lars Fruergaard Jørgensen who helmed it all, and presses him on the high price, drug shortages, and long ...